Published 09/19/2024 2:58:36 p.m.

First cases completed in SPIRARE I trial with Vertex system

Summary by Interventional News

Vertex PE system Jupiter Endovascular has announced that the first two patients have been treated in SPIRARE I, a multicentre study of the Vertex pulmonary embolectomy system using the company’s Endoportal Control platform technology. The Vertex system is designed to treat acute pulmonary embolism (PE) in an endovascular procedure. The successful first two cases were performed at St John Paul II Hospital in Krakow, Poland, a cardiothoracic speci…

0 Articles

All

Left

Center

Right

Cardiac Interventions Today

Jupiter SPIRARE I FIH Trial of Vertex Pulmonary Embolectomy System Commences - Cardiac Interventions Today

September 19, 2024—Jupiter Endovascular, Inc. announced that the first two patients were treated in the SPIRARE I trial of the Vertex pulmonary embolectomy system using the company’s Endoportal Control platform technology. SPIRARE I is a prospective, single-arm, multicenter study enrolling patients with acute, intermediate-risk pulmonary embolism (PE) treated with the Vertex system. According to the company, trial endpoints will characterize the…

09/19/2024 9:41:26 p.m.

Read Full Article